Long-term Study to Evaluate Safety and Persistence of GF-CART01
GenomeFrontier Therapeutics TW Co., Ltd.
GenomeFrontier Therapeutics TW Co., Ltd.
Hospices Civils de Lyon
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Vanderbilt University Medical Center
Columbia University
Mayo Clinic
SWOG Cancer Research Network
Vanderbilt-Ingram Cancer Center